Page last updated: 2024-08-26

fulvestrant and Pulmonary Hypertension

fulvestrant has been researched along with Pulmonary Hypertension in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's4 (80.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Austin, ED; Brittain, EL; Chen, X; Farber-Eger, EH; Fessel, JP; Hemnes, AR; Loyd, JE; Talati, M; West, J1
Baden, H; Ichimori, H; Ishida, H; Kogaki, S; Narita, J; Nawa, N; Okada, Y; Ozono, K; Takahashi, K; Uchikawa, T1
Artem'eva, MM; Kovaleva, IuO; Medvedev, OS; Medvedeva, NA1
Albrecht, M; Brown, JA; Brown, MB; Dieudonne, D; Fisher, AJ; Justice, MJ; Lahm, T; Patel, NG; Petrache, I; Presson, RG; Reddy, JG; Selej, M; Trulock, KM; Van Demark, M1
Hill, NS; Karamsetty, MR; Klinger, JR1

Other Studies

5 other study(ies) available for fulvestrant and Pulmonary Hypertension

ArticleYear
Oestrogen inhibition reverses pulmonary arterial hypertension and associated metabolic defects.
    The European respiratory journal, 2017, Volume: 50, Issue:2

    Topics: Anastrozole; Animals; Bone Morphogenetic Protein Receptors, Type II; Disease Models, Animal; Echocardiography; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Hemodynamics; Humans; Hypertension, Pulmonary; Insulin Resistance; Lung; Mice; Mice, Knockout; Mutation; Nitriles; Signal Transduction; Tamoxifen; Triazoles

2017
Drastic shift from positive to negative estrogen effect on bone morphogenetic protein signaling in pulmonary arterial endothelial cells under hypoxia.
    Circulation journal : official journal of the Japanese Circulation Society, 2013, Volume: 77, Issue:8

    Topics: Bone Morphogenetic Proteins; Cell Hypoxia; Cells, Cultured; Cycloheximide; Endothelial Cells; Estradiol; Estrogen Antagonists; Estrogens; Fulvestrant; Humans; Hypertension, Pulmonary; Hypoxia-Inducible Factor 1, alpha Subunit; Protein Synthesis Inhibitors; Pulmonary Artery; Signal Transduction; Smad Proteins

2013
[Chronic administration of estrogen receptors antagonist reduces degree of hypoxia-induced pulmonary hypertension caused by chronic injections of estrogen in ovariectomised female Wistar rats].
    Eksperimental'naia i klinicheskaia farmakologiia, 2013, Volume: 76, Issue:7

    Topics: Animals; Estradiol; Estrogen Antagonists; Estrogen Receptor alpha; Estrogen Receptor beta; Estrogens; Familial Primary Pulmonary Hypertension; Female; Fulvestrant; Hypertension, Pulmonary; Hypoxia; Ovariectomy; Rats; Rats, Wistar

2013
17β-Estradiol attenuates hypoxic pulmonary hypertension via estrogen receptor-mediated effects.
    American journal of respiratory and critical care medicine, 2012, May-01, Volume: 185, Issue:9

    Topics: Airway Remodeling; Animals; Blood Pressure; Cardiac Output; Cyclin-Dependent Kinase Inhibitor p27; Estradiol; Estrogen Antagonists; Fulvestrant; Hypertension, Pulmonary; Hypoxia; Lung; Male; Neovascularization, Pathologic; Rats; Rats, Sprague-Dawley; Receptors, Estrogen; Ventricular Remodeling

2012
Phytoestrogens restore nitric oxide-mediated relaxation in isolated pulmonary arteries from chronically hypoxic rats.
    The Journal of pharmacology and experimental therapeutics, 2001, Volume: 297, Issue:3

    Topics: Animals; Carbachol; Cholinergic Agonists; Chronic Disease; Dose-Response Relationship, Drug; Estradiol; Estrogen Antagonists; Estrogens, Non-Steroidal; Fulvestrant; Genistein; Hypertension, Pulmonary; Hypoxia; In Vitro Techniques; Isoflavones; Male; Nitric Oxide; Nitric Oxide Synthase; Phytoestrogens; Plant Preparations; Pulmonary Artery; Rats; Rats, Sprague-Dawley; Vasoconstriction; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents

2001